Cargando…

Is androgen deprivation therapy associated with cerebral infarction in patients with prostate cancer? A Korean nationwide population‐based propensity score matching study

PURPOSE: Previous studies have suggested that androgen deprivation therapy (ADT) is associated with cerebral infarction. However, conflicting results have been reported by other researchers. The aim of this study was to evaluate the association between ADT and cerebral infarction in patients with pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Tae, Bum Sik, Jeon, Byeong Jo, Choi, Hoon, Bae, Jae Hyun, Park, Jae Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6675721/
https://www.ncbi.nlm.nih.gov/pubmed/31183968
http://dx.doi.org/10.1002/cam4.2325
_version_ 1783440653489799168
author Tae, Bum Sik
Jeon, Byeong Jo
Choi, Hoon
Bae, Jae Hyun
Park, Jae Young
author_facet Tae, Bum Sik
Jeon, Byeong Jo
Choi, Hoon
Bae, Jae Hyun
Park, Jae Young
author_sort Tae, Bum Sik
collection PubMed
description PURPOSE: Previous studies have suggested that androgen deprivation therapy (ADT) is associated with cerebral infarction. However, conflicting results have been reported by other researchers. The aim of this study was to evaluate the association between ADT and cerebral infarction in patients with prostate cancer (PC) using big data. MATERIALS AND METHODS: Using information from the National Health Insurance Service database representative of the entire Korean adult PC population (n = 206 735), data regarding ADT and cerebral infarction between 2009 and 2016 were analyzed. Adjusted hazard ratios for cerebral infarction associated with ADT were estimated using propensity score‐matched Cox proportional hazards models and Kaplan‐Meier survival analyses. RESULTS: The final cohort comprised 36 146 individuals with PC, including 24 069 men (66.6%) who underwent ADT. During the mean follow‐up of 4.1 years, 2792 patients were newly diagnosed with cerebral infarction. In the unmatched cohort, there was a significant difference in the annual incidence of cerebral infarction between the ADT and non‐ADT groups (22.8 vs 14.6 per 1000 person‐years, respectively). However, there was no significant difference between the ADT and non‐ADT groups in the matched cohort (14.9 vs 14.6 per 1000 person‐years). The adjusted hazard ratio for cerebral infarction for PC patients who underwent ADT was 1.045 (95% CI 0.943‐1.159; P = 0.401) compared with those who did not undergo ADT. In addition, the cumulative duration of ADT was also not associated with an increased risk for cerebral infarction. However, older age, hypertension, diabetes, myocardial infarction, congestive heart failure, peripheral vascular disease, renal disease, dementia, and atrial fibrillation were revealed to be factors contributing to cerebral infarction. CONCLUSION: This nationwide population‐based study revealed that ADT was not associated with cerebral infarction after adjusting for potential confounders.
format Online
Article
Text
id pubmed-6675721
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-66757212019-08-06 Is androgen deprivation therapy associated with cerebral infarction in patients with prostate cancer? A Korean nationwide population‐based propensity score matching study Tae, Bum Sik Jeon, Byeong Jo Choi, Hoon Bae, Jae Hyun Park, Jae Young Cancer Med Cancer Prevention PURPOSE: Previous studies have suggested that androgen deprivation therapy (ADT) is associated with cerebral infarction. However, conflicting results have been reported by other researchers. The aim of this study was to evaluate the association between ADT and cerebral infarction in patients with prostate cancer (PC) using big data. MATERIALS AND METHODS: Using information from the National Health Insurance Service database representative of the entire Korean adult PC population (n = 206 735), data regarding ADT and cerebral infarction between 2009 and 2016 were analyzed. Adjusted hazard ratios for cerebral infarction associated with ADT were estimated using propensity score‐matched Cox proportional hazards models and Kaplan‐Meier survival analyses. RESULTS: The final cohort comprised 36 146 individuals with PC, including 24 069 men (66.6%) who underwent ADT. During the mean follow‐up of 4.1 years, 2792 patients were newly diagnosed with cerebral infarction. In the unmatched cohort, there was a significant difference in the annual incidence of cerebral infarction between the ADT and non‐ADT groups (22.8 vs 14.6 per 1000 person‐years, respectively). However, there was no significant difference between the ADT and non‐ADT groups in the matched cohort (14.9 vs 14.6 per 1000 person‐years). The adjusted hazard ratio for cerebral infarction for PC patients who underwent ADT was 1.045 (95% CI 0.943‐1.159; P = 0.401) compared with those who did not undergo ADT. In addition, the cumulative duration of ADT was also not associated with an increased risk for cerebral infarction. However, older age, hypertension, diabetes, myocardial infarction, congestive heart failure, peripheral vascular disease, renal disease, dementia, and atrial fibrillation were revealed to be factors contributing to cerebral infarction. CONCLUSION: This nationwide population‐based study revealed that ADT was not associated with cerebral infarction after adjusting for potential confounders. John Wiley and Sons Inc. 2019-06-10 /pmc/articles/PMC6675721/ /pubmed/31183968 http://dx.doi.org/10.1002/cam4.2325 Text en © 2019 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Cancer Prevention
Tae, Bum Sik
Jeon, Byeong Jo
Choi, Hoon
Bae, Jae Hyun
Park, Jae Young
Is androgen deprivation therapy associated with cerebral infarction in patients with prostate cancer? A Korean nationwide population‐based propensity score matching study
title Is androgen deprivation therapy associated with cerebral infarction in patients with prostate cancer? A Korean nationwide population‐based propensity score matching study
title_full Is androgen deprivation therapy associated with cerebral infarction in patients with prostate cancer? A Korean nationwide population‐based propensity score matching study
title_fullStr Is androgen deprivation therapy associated with cerebral infarction in patients with prostate cancer? A Korean nationwide population‐based propensity score matching study
title_full_unstemmed Is androgen deprivation therapy associated with cerebral infarction in patients with prostate cancer? A Korean nationwide population‐based propensity score matching study
title_short Is androgen deprivation therapy associated with cerebral infarction in patients with prostate cancer? A Korean nationwide population‐based propensity score matching study
title_sort is androgen deprivation therapy associated with cerebral infarction in patients with prostate cancer? a korean nationwide population‐based propensity score matching study
topic Cancer Prevention
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6675721/
https://www.ncbi.nlm.nih.gov/pubmed/31183968
http://dx.doi.org/10.1002/cam4.2325
work_keys_str_mv AT taebumsik isandrogendeprivationtherapyassociatedwithcerebralinfarctioninpatientswithprostatecancerakoreannationwidepopulationbasedpropensityscorematchingstudy
AT jeonbyeongjo isandrogendeprivationtherapyassociatedwithcerebralinfarctioninpatientswithprostatecancerakoreannationwidepopulationbasedpropensityscorematchingstudy
AT choihoon isandrogendeprivationtherapyassociatedwithcerebralinfarctioninpatientswithprostatecancerakoreannationwidepopulationbasedpropensityscorematchingstudy
AT baejaehyun isandrogendeprivationtherapyassociatedwithcerebralinfarctioninpatientswithprostatecancerakoreannationwidepopulationbasedpropensityscorematchingstudy
AT parkjaeyoung isandrogendeprivationtherapyassociatedwithcerebralinfarctioninpatientswithprostatecancerakoreannationwidepopulationbasedpropensityscorematchingstudy